Mandel A - Search Results

1

A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome.

Osborne LR, Li M, Pober B, Chitayat D, Bodurtha J, Mandel A, Costa T, Grebe T, Cox S, Tsui LC, Scherer SW. Osborne LR, et al. Among authors: mandel a. Nat Genet. 2001 Nov;29(3):321-5. doi: 10.1038/ng753. Nat Genet. 2001. PMID: 11685205 Free PMC article.

2

Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice.

Young EJ, Lipina T, Tam E, Mandel A, Clapcote SJ, Bechard AR, Chambers J, Mount HT, Fletcher PJ, Roder JC, Osborne LR. Young EJ, et al. Among authors: mandel a. Genes Brain Behav. 2008 Mar;7(2):224-34. doi: 10.1111/j.1601-183X.2007.00343.x. Epub 2007 Aug 3. Genes Brain Behav. 2008. PMID: 17680805 Free PMC article.

3

The effect of VAS972 on allergic contact hypersensitivity.

Shivji GM, Suzuki H, Mandel AS, Bolton AE, Sauder DN. Shivji GM, et al. Among authors: mandel as. J Cutan Med Surg. 2000 Jul;4(3):132-7. doi: 10.1177/120347540000400304. J Cutan Med Surg. 2000. PMID: 11003717

4

Non PUVA nonsurgical therapies for vitiligo.

Mandel AS, Haberman HF, Pawlowski D, Goldstein E. Mandel AS, et al. Clin Dermatol. 1997 Nov-Dec;15(6):907-19. doi: 10.1016/s0738-081x(97)00132-6. Clin Dermatol. 1997. PMID: 9404694 Review. No abstract available.

5

Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease.

Fitzgerald P, Mandel A, Bolton AE, Sullivan AM, Nolan Y. Fitzgerald P, et al. Among authors: mandel a. Behav Brain Res. 2008 Dec 22;195(2):271-4. doi: 10.1016/j.bbr.2008.08.041. Epub 2008 Sep 4. Behav Brain Res. 2008. PMID: 18817814

6

Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.

Crotty S, Fitzgerald P, Tuohy E, Harris DM, Fisher A, Mandel A, Bolton AE, Sullivan AM, Nolan Y. Crotty S, et al. Among authors: mandel a. Eur J Neurosci. 2008 Jan;27(2):294-300. doi: 10.1111/j.1460-9568.2007.06018.x. Epub 2008 Jan 11. Eur J Neurosci. 2008. PMID: 18190522

7

The deficit in long-term potentiation induced by chronic administration of amyloid-beta is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025.

Miller AM, Piazza A, Martin DS, Walsh M, Mandel A, Bolton AE, Lynch MA. Miller AM, et al. Among authors: mandel a. Exp Gerontol. 2009 Apr;44(4):300-4. doi: 10.1016/j.exger.2008.12.001. Epub 2008 Dec 11. Exp Gerontol. 2009. PMID: 19121379

8

A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat.

Martin DS, Walsh M, Miller AM, Skerrett HE, Byrne P, Mandel A, Bolton AE, Lynch MA. Martin DS, et al. Among authors: mandel a. Neuroimmunomodulation. 2009;16(6):400-10. doi: 10.1159/000228915. Epub 2009 Jul 17. Neuroimmunomodulation. 2009. PMID: 19609089

9

Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?

McFarland SA, Mandel A, Dumoulin-White R, Gasser G. McFarland SA, et al. Among authors: mandel a. Curr Opin Chem Biol. 2020 Jun;56:23-27. doi: 10.1016/j.cbpa.2019.10.004. Epub 2019 Nov 20. Curr Opin Chem Biol. 2020. PMID: 31759225 Free PMC article. Review.

10

Novel Osmium-based Coordination Complexes as Photosensitizers for Panchromatic Photodynamic Therapy.

Lazic S, Kaspler P, Shi G, Monro S, Sainuddin T, Forward S, Kasimova K, Hennigar R, Mandel A, McFarland S, Lilge L. Lazic S, et al. Among authors: mandel a. Photochem Photobiol. 2017 Oct;93(5):1248-1258. doi: 10.1111/php.12767. Epub 2017 Jun 13. Photochem Photobiol. 2017. PMID: 28370264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page